Iran Insulin Drugs and Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Iranian Insulin Drugs and Delivery Devices Market Report is Segmented Into Products (Drugs (Basal or Long-Acting Insulins, Bolus or Fast-Acting Insulins, Traditional Human Insulins, and Other Products) and Devices (Insulin Pens, Insulin Pumps, Insulin Syringes, and Jet Injectors)). The Report Offers the Market Size and Forecasts for the Iranian Insulin Drugs and Delivery Devices Market in Value (USD) for the Above Segments.

Iran Insulin Drugs and Delivery Devices Market Size

Compare market size and growth of Iran Insulin Drugs And Delivery Devices Market with other markets in Healthcare Industry

Iran Insulin Drugs and Delivery Devices Market Analysis

The Iran Insulin Drugs And Delivery Devices Market size is estimated at USD 352.02 million in 2025, and is expected to reach USD 392.10 million by 2030, at a CAGR of 2.18% during the forecast period (2025-2030).

The Iranian insulin drugs and delivery devices market is evolving rapidly due to increasing diabetes prevalence, innovative research, and supportive government policies.

Diabetes, a major public health concern in Iran, has prompted significant changes in the insulin drugs and delivery devices market. The acceleration in the prevalence of diabetes has led to an increased demand for effective insulin therapies and advanced delivery systems.

As per the study published in Health Science Reports in February 2023, diabetes imposes a substantial economic burden on Iran’s healthcare system and economy. The study highlights that patients with diabetes and related complications incur higher costs, underscoring the need for more efficient and cost-effective treatment options. This economic impact has spurred both government and private sector efforts to address the diabetes crisis through improved treatment modalities and support mechanisms.

Market growth is primarily driven by an increasing diabetic patient population, heightened awareness of diabetes management, and government efforts to enhance access to affordable healthcare. However, the market faces constraints due to the high prices of insulin, especially given the significant portion of the population with limited purchasing power.

Iran Insulin Drugs and Delivery Devices Industry Overview

The Iranian insulin drugs and delivery devices market is consolidated, with few significant and generic players. The major players are working on innovations in insulin drugs and devices, which is evident from the companies' spending on research and developments to strengthen their market presence. The key players in the market include Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Gan & Lee Pharmaceuticals, and Becton, Dickinson and Company.

Iran Insulin Drugs and Delivery Devices Market Leaders

  1. Novo Nordisk A/S

  2. Gan & Lee Pharmaceuticals

  3. Sanofi

  4. Eli Lilly and Company

  5. Becton, Dickinson and Company

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

Iran Insulin Drugs and Delivery Devices Market News

  • September 2024: The Vice President of Food and Drugs at Hamedan University of Medical Sciences announced the introduction of a foreign insulin brand, Raizodag. The insulin, akin to the Nomix brand, was launched. It is covered by health insurance and the Armed Forces Medical Services insurance. The authority anticipates that Social Security insurance will extend its coverage soon.
  • September 2023: The Food and Drug Organization inaugurated Iran's first insulin raw material production line. This development underscores the nation's incremental strides toward establishing a comprehensive insulin production chain and achieving self-sufficiency.

Iran Insulin Drugs and Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Strategic Initiatives by the Government and Organizations
    • 4.2.2 Increasing Prevalence of Diabetes in Iran
  • 4.3 Market Restraints
    • 4.3.1 Limited Availability of Affordable Insulin Pumps in the Country
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size By Value - USD)

  • 5.1 By Product Type
    • 5.1.1 By Drug
    • 5.1.1.1 Basal or Long-acting Insulins
    • 5.1.1.2 Bolus or Fast-acting Insulins
    • 5.1.1.3 Traditional Human Insulins
    • 5.1.1.4 Other Product Types
    • 5.1.2 By Device
    • 5.1.2.1 Insulin Pumps
    • 5.1.2.2 Insulin Pens
    • 5.1.2.3 Insulin Syringes
    • 5.1.2.4 Insulin Jet Injectors

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Novo Nordisk A/S
    • 7.1.2 Sanofi
    • 7.1.3 Eli Lilly and Company
    • 7.1.4 Gan & Lee Pharmaceuticals
    • 7.1.5 Biocon
    • 7.1.6 Medtronic
    • 7.1.7 Becton, Dickinson and Company
  • *List Not Exhaustive

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Iran Insulin Drugs and Delivery Devices Industry Segmentation

The Iranian insulin drugs and delivery devices market is segmented into products. By products, the market is segmented into drugs and devices. By drugs, the market is segmented into basal or long-acting insulins, bolus or fast-acting insulins, traditional human insulins, and other drugs. By devices, the market is segmented into insulin pens, insulin pumps, insulin syringes, and jet injectors. The report offers the market size and forecasts for the Iranian insulin drugs and delivery devices market in value (USD) for the above segments.

By Product Type By Drug Basal or Long-acting Insulins
Bolus or Fast-acting Insulins
Traditional Human Insulins
Other Product Types
By Device Insulin Pumps
Insulin Pens
Insulin Syringes
Insulin Jet Injectors
By Product Type
By Drug Basal or Long-acting Insulins
Bolus or Fast-acting Insulins
Traditional Human Insulins
Other Product Types
By Device Insulin Pumps
Insulin Pens
Insulin Syringes
Insulin Jet Injectors
Need A Different Region or Segment?
Customize Now

Iran Insulin Drugs and Delivery Devices Market Research FAQs

How big is the Iran Insulin Drugs And Delivery Devices Market?

The Iran Insulin Drugs And Delivery Devices Market size is expected to reach USD 352.02 million in 2025 and grow at a CAGR of 2.18% to reach USD 392.10 million by 2030.

What is the current Iran Insulin Drugs And Delivery Devices Market size?

In 2025, the Iran Insulin Drugs And Delivery Devices Market size is expected to reach USD 352.02 million.

Who are the key players in Iran Insulin Drugs And Delivery Devices Market?

Novo Nordisk A/S, Gan & Lee Pharmaceuticals, Sanofi, Eli Lilly and Company and Becton, Dickinson and Company are the major companies operating in the Iran Insulin Drugs And Delivery Devices Market.

What years does this Iran Insulin Drugs And Delivery Devices Market cover, and what was the market size in 2024?

In 2024, the Iran Insulin Drugs And Delivery Devices Market size was estimated at USD 344.35 million. The report covers the Iran Insulin Drugs And Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Iran Insulin Drugs And Delivery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Page last updated on: September 24, 2024

Iran Insulin Drugs and Delivery Devices Industry Report

Statistics for the 2025 Iran Insulin Drugs And Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Iran Insulin Drugs And Delivery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Iran Insulin Drugs and Delivery Devices Market Report Snapshots